Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
69 0 » 6 0 (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
69 0 » 6 0 (Expand Search)
-
221
-
222
Estimated variation in <i>R</i> <i><sub> t </sub></i> (%, and its 95% CI) associated with other driving factors when the mean of serial interval was assumed 2 or 5 days and the end of an epidemic was defined as decreasing for not less than 6-, 7- or 9-weeks using GAMs.
Published 2025“…<p> Estimated variation in <i>R</i> <i><sub> t </sub></i> (%, and its 95% CI) associated with other driving factors when the mean of serial interval was assumed 2 or 5 days and the end of an epidemic was defined as decreasing for not less than 6-, 7- or 9-weeks using GAMs. …”
-
223
Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA.
Published 2009“…Luciferase activity is represented as mean ± SEM fold increase from four experiments. *, <i>p</i><0.05 vs. the corresponding time point of PC12 cells without exogenous PC3, Student's t test. …”
-
224
-
225
-
226
Average nearest neighbour analysis before and after filtering of data points.
Published 2022Subjects: -
227
The mean and standard deviation of parameters.
Published 2024“…Additionally, one-way ANCOVA revealed a significant difference between the groups post-treatment (F(1,31) = 6.011, P = 0.020, η2 = 0.162) and one month post-treatment (F(1,31) = 4.889, P = 0.035, η2 = 0.136), with ML SI being significantly lower in the exergaming group than the balance training group at both time points. In both group, the DPSI also decreased significantly one month post-treatment compared to before and after treatment (P = 0.040 and P = 0.018, respectively). …”
-
228
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
-
229
-
230
-
231
-
232
-
233
-
234
(R+S) and (R)-albuterol decrease NF-κB activity
Published 2011“…<p><b>Copyright information:</b></p><p>Taken from "(R)-albuterol decreases immune responses: role of activated T cells"</p><p>Respiratory Research 2008;9(1):3-3.…”
-
235
-
236
-
237
-
238
Hematopoietic potential decreases in ESC with down-regulation of junction molecules.
Published 2011“…C) TF expression level linearly correlates with decreased frequency of CD45+ cells. Gata1: R<sup>2</sup> = 0.87; Runx1: R<sup>2</sup> = 0.91; Scl: R<sup>2</sup> = 0.69. …”
-
239
-
240